417 related articles for article (PubMed ID: 22358400)
1. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
[TBL] [Abstract][Full Text] [Related]
2. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
[TBL] [Abstract][Full Text] [Related]
3. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
4. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa].
Yi MY; Wang PY; Huang HJ; Liu YC
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):457-62. PubMed ID: 16677571
[TBL] [Abstract][Full Text] [Related]
5. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
[TBL] [Abstract][Full Text] [Related]
6. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
[TBL] [Abstract][Full Text] [Related]
7. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
Shu JC; Su LH; Chiu CH; Kuo AJ; Liu TP; Lee MH; Su IN; Wu TL
Microb Drug Resist; 2015 Apr; 21(2):149-57. PubMed ID: 25386722
[TBL] [Abstract][Full Text] [Related]
8. Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment.
Shen JL; Fang YP
Genet Mol Res; 2015 Jun; 14(2):6723-32. PubMed ID: 26125881
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
[TBL] [Abstract][Full Text] [Related]
11. Efflux system overexpression and decreased OprD contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa isolates from a Chinese university hospital.
Liu Y; Li XY; Wan LG; Jiang WY; Li FQ; Yang JH
Microb Drug Resist; 2013 Dec; 19(6):463-8. PubMed ID: 23865862
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
13. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).
Shu JC; Chia JH; Siu LK; Kuo AJ; Huang SH; Su LH; Wu TL
Int J Antimicrob Agents; 2012 Mar; 39(3):217-22. PubMed ID: 22079532
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
[TBL] [Abstract][Full Text] [Related]
15. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.
Ocampo-Sosa AA; Cabot G; Rodríguez C; Roman E; Tubau F; Macia MD; Moya B; Zamorano L; Suárez C; Peña C; Domínguez MA; Moncalián G; Oliver A; Martínez-Martínez L;
Antimicrob Agents Chemother; 2012 Apr; 56(4):1703-13. PubMed ID: 22290967
[TBL] [Abstract][Full Text] [Related]
16. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.
Quale J; Bratu S; Gupta J; Landman D
Antimicrob Agents Chemother; 2006 May; 50(5):1633-41. PubMed ID: 16641429
[TBL] [Abstract][Full Text] [Related]
17. First detected OXA-50 carbapenem-resistant clinical isolates
Petrova A; Feodorova Y; Miteva-Katrandzhieva T; Petrov M; Murdjeva M
J Med Microbiol; 2019 Dec; 68(12):1723-1731. PubMed ID: 31746726
[No Abstract] [Full Text] [Related]
18. Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential.
Mushtaq S; Ge Y; Livermore DM
Antimicrob Agents Chemother; 2004 Aug; 48(8):3086-92. PubMed ID: 15273124
[TBL] [Abstract][Full Text] [Related]
19. Mutational and acquired carbapenem resistance mechanisms in multidrug resistant Pseudomonas aeruginosa clinical isolates from Recife, Brazil.
Cavalcanti FL; Mirones CR; Paucar ER; Montes LÁ; Leal-Balbino TC; Morais MM; Martínez-Martínez L; Ocampo-Sosa AA
Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):1003-9. PubMed ID: 26676375
[TBL] [Abstract][Full Text] [Related]
20. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]